InnoCare Pharma Limited (HKG:9969)

InnoCare Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	24,433	23,687	12,220	13,112	23,452	21,094
Market Cap Growth	21.13%	93.84%	-6.80%	-44.09%	11.18%	21.38%
Enterprise Value	18,451	17,849	6,114	4,689	14,292	15,136
Last Close Price	11.75	12.30	6.12	6.89	13.64	15.30
PE Ratio	23.81	33.13	-	-	-	-
PS Ratio	8.52	8.96	11.38	16.11	33.17	16.48
PB Ratio	2.92	2.75	1.70	1.66	2.71	3.04
P/TBV Ratio	3.03	2.85	1.78	1.73	2.75	3.09
P/FCF Ratio	-	1548.92	-	-	-	-
P/OCF Ratio	680.30	253.70	-	-	-	102.87
EV/Sales Ratio	6.44	6.75	5.69	5.76	20.22	11.82
EV/EBITDA Ratio	24.73	30.23	-	-	-	-
EV/EBIT Ratio	29.72	35.46	-	-	-	-
EV/FCF Ratio	-372.83	1167.14	-	-	-	-
Debt / Equity Ratio	0.25	0.21	0.23	0.23	0.20	0.23
Debt / EBITDA Ratio	2.76	2.88	-	-	-	-
Debt / FCF Ratio	-	117.24	-	-	-	-
Net Debt / Equity Ratio	-0.72	-0.70	-0.80	-0.92	-0.98	-0.87
Net Debt / EBITDA Ratio	-8.43	-10.29	12.00	10.84	10.21	29.54
Net Debt / FCF Ratio	121.30	-397.39	12.23	7.21	9.42	1821.44
Asset Turnover	0.26	0.24	0.10	0.07	0.07	0.18
Inventory Turnover	1.61	1.48	1.29	1.39	3.81	11.13
Quick Ratio	5.23	5.47	7.01	4.13	4.43	19.29
Current Ratio	5.65	5.83	7.45	4.21	4.48	19.49
Return on Equity (ROE)	10.36%	8.89%	-6.50%	-8.71%	-13.44%	-1.51%
Return on Assets (ROA)	3.45%	2.79%	-3.37%	-4.15%	-5.48%	-1.91%
Return on Invested Capital (ROIC)	24.59%	24.63%	-55.80%	-186.05%	-174.16%	-33.69%
Return on Capital Employed (ROCE)	6.10%	4.80%	-6.20%	-8.60%	-9.40%	-2.60%
Earnings Yield	3.40%	3.02%	-3.84%	-5.30%	-4.27%	-0.38%
FCF Yield	-0.20%	0.07%	-3.86%	-7.73%	-3.82%	-0.02%
Payout Ratio	4.61%	5.13%	-	-	-	-
Buyback Yield / Dilution	0.97%	0.24%	0.67%	-15.31%	-8.29%	-41.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.